American International Group, Inc. Talaris Therapeutics, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.09 - $2.09 $240 - $461	221 Added 2.03%	11,132 $20,000
Q4 2022 Feb 10, 2023	SELL	$0.94 - $1.64 $36 - $63	-39 Reduced 0.36%	10,911 $11,000
Q3 2022 Nov 14, 2022	BUY	$2.3 - $5.03 $1,046 - $2,288	455 Added 4.34%	10,950 $29,000
Q2 2022 Aug 12, 2022	SELL	$4.51 - $9.85 $392 - $856	-87 Reduced 0.82%	10,495 $47,000
Q1 2022 May 13, 2022	SELL	$6.89 - $16.56 $5,139 - $12,353	-746 Reduced 6.59%	10,582 $104,000
Q4 2021 Feb 11, 2022	BUY	$12.18 - $17.0 $76,734 - $107,100	6,300 Added 125.3%	11,328 $173,000
Q3 2021 Nov 12, 2021	BUY	$11.61 - $15.99 $429 - $591	37 Added 0.74%	5,028 $68,000
Q2 2021 Aug 13, 2021	BUY	$12.25 - $18.61 $61,139 - $92,882	4,991 New	4,991 $73,000

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.